Concepedia

Sakkaraiappan Ramalingam

SR

Statistics

Publications

13

Citations

836

H-Index

11

Active since

1995

Affiliations

University of Pittsburgh(Current)

UPMC Hillman Cancer Center

Johns Hopkins University

Wayne State University

The Barbara Ann Karmanos Cancer Institute

Sakkaraiappan Ramalingam is an author at University of Pittsburgh specializing in medicine, oncology, and pharmacology.

Publications per year

1995–2016

13

Publications

13

Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database.

Sakkaraiappan Ramalingam, Karen Pawlish, Shirish M. Gadgeel et al. · Journal of Clinical Oncology · 1998 · 200 citations

, , +15

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers

Ramesh K. Ramanathan, Donald L. Trump, Julie L. Eiseman et al. · Clinical Cancer Research · 2005 · 192 citations · Full text

, , +17

Intravesical Gemcitabine Therapy for Superficial Transitional Cell Carcinoma of the Bladder: A Phase I and Pharmacokinetic Study

Menachem Laufer, Sakkaraiappan Ramalingam, Mark Schoenberg et al. · Journal of Clinical Oncology · 2003 · 103 citations

, , +12

Growth Inhibition and Induction of Apoptosis by Fenretinide in Small-Cell Lung Cancer Cell Lines

Gregory P. Kalemkerian, Rodney Slusher, Sakkaraiappan Ramalingam et al. · JNCI Journal of the National Cancer Institute · 1995 · 102 citations

, , +14

Lung Cancer in Patients < 50 Years of Age

Shirish M. Gadgeel, Sakkaraiappan Ramalingam, Glenn Cummings et al. · CHEST Journal · 1999 · 75 citations

, , +8

1–5 of 13